Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Is The Internal Neuromodulation Devices Market Size Likely To Evolve From 2025 Through 2034?
Strong recent expansion has characterized the internal neuromodulation devices market, with its valuation set to increase from $2.59 billion in 2024 to $2.75 billion by 2025, reflecting a steady compound annual growth rate of 6.0%; this upward trajectory during the past period resulted from several key factors, including the increasing need for chronic pain treatment solutions, demographic shifts toward an older populace, ongoing clinical investigations and testing, the rising incidence of neurological conditions, alongside growing patient knowledge and approval of these technologies.
Projected to experience substantial expansion, the market encompassing internal neuromodulation devices is anticipated to reach a valuation of $3.87 billion by the year 2029, exhibiting a consistent annual growth rate, or CAGR, of 8.9% throughout the projection timeframe, with this upward trajectory being fueled by several key factors such as the growing emphasis on individualized medical treatments, escalating spending within the healthcare sector, the prevalence of strategic alliances and cooperative agreements, increasing reliance on demonstrated patient benefits and verifiable evidence from actual clinical practice, alongside shifts in the governing regulatory environment, while significant developments shaping this landscape throughout the forecast involve the trend toward smaller, more sophisticated implantable technological solutions, advancements in wireless communication capabilities enabling remote observation, the broadening spectrum of conditions addressed by neuromodulation techniques, the adoption of automated systems for highly accurate signal adjustment, and a sustained concentration on creating designs that prioritize the comfort and needs of the patient.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10222&type=smp
Which Drivers Are Shaping The Internal Neuromodulation Devices Industry’s Market Share?
Anticipated escalation in the prevalence of neurological ailments is set to fuel the expansion of the market for internal neuromodulation devices. These devices, employed to manage both neurological and psychiatric conditions, function by sending electrical impulses to targeted regions of the nervous system, thereby alleviating symptoms such as persistent pain, difficulties with movement, and mood disturbances, ultimately enhancing sufferers’ daily functioning and overall well-being. A compelling illustration of this growing burden is the data from the US National Library Medicine in April 2023, which indicated that the count of Americans afflicted with Alzheimer’s disease stood at 6.7 million in 2023, a figure expected to nearly double to 13.8 million by the year 2060. Further supporting this trend, data from the UK’s House of Lords Library in May 2022 showed a continuous strengthening of the specialized workforce in England, reporting 1,638 full-time equivalent neurology staff as of January 31, 2022, marking an uptick from 1,562 staff in 2021 and 1,468 in 2020. Consequently, the rising occurrence rates of these nervous system disorders are directly propelling the trajectory of the internal neuromodulation devices market forward.
What Are The Primary Types Of Segments Analyzed In The Internal Neuromodulation Devices Market?
The internal neuromodulation devicesmarket covered in this report is segmented –
1) By Type: Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neuro Stimulator
2) By Technology Type: Internal Neuromodulation, External Neuromodulation
3) By Biomaterial: Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials
4) By Application: Failed Back Surgery Syndrome, Parkinson’s Disease, Urinary Incontinence, Epilepsy, Gastroparesis
5) By End-User: Hospitals, Clinics, Home Healthcare, Community Healthcare
Subsegments:
1) By Spinal Cord Stimulator: Traditional Spinal Cord Stimulator, Rechargeable Spinal Cord Stimulator, Non-Rechargeable Spinal Cord Stimulator
2) By Deep Brain Stimulator: Single Lead Deep Brain Stimulator, Dual Lead Deep Brain Stimulator, Adaptive Deep Brain Stimulator
3) By Sacral Nerve Stimulator: Implantable Sacral Nerve Stimulator, External Sacral Nerve Stimulator
4) By Vagus Nerve Stimulator: Implantable Vagus Nerve Stimulator, Transcutaneous Vagus Nerve Stimulator
5) By Gastric Neuro Stimulator: Implantable Gastric Neuro Stimulator, External Gastric Neuro Stimulator
How Are Emerging Market Trends Shaping The Internal Neuromodulation Devices Industry Landscape?
A significant trend observed within the market for internal neuromodulation devices is the increasing emphasis on developing novel products. Key players in the internal neuromodulation device sphere are actively concentrating on pioneering fresh technological advancements as a means to solidify their standing. As an illustration, in March of 2023, Neuromod Device Ltd., an Irish producer of medical apparatus, publicly stated that its Lenire apparatus had successfully obtained De Novo authorization from the US Food and Drug Administration (FDA). This Lenire system employs a dual-modality method, integrating acoustic stimulation with electrical stimulation of the tongue, in order to provide relief for tinnitus, which is a neurological condition manifesting as ear ringing. The neurostimulation delivered by the Lenire system involves a two-part methodology: unique auditory signals, broadcast via Bluetooth headphones, aim to activate the auditory nerve, concurrently with the Neuromod Tonguetip instrument delivering controlled electrical impulses to the tongue’s surface. Consequently, otolaryngologists are now equipped with the advanced Lenire solution, enabling them to suggest this treatment option for individuals whose experience with tinnitus is negatively affecting their daily existence to at least a moderate degree.
Who Are The Core Companies Influencing The Internal Neuromodulation Devices Market Landscape?
Major companies operating in the internal neuromodulation devices market include Medtronic plc, Boston Scientific Corporation, BioControl Medical Ltd., Aleva Neurotherapeutics SA, Bioness Inc., Uroplasty Inc., Abbott Laboratories, EnteroMedics Inc., LivaNova plc, NeuroPace Inc., Synapse Biomedical Inc., Soterix Medical Inc., Neuros Medical Inc., Nevro Corp., Nuvectra Corporation, Stimwave Technologies Incorporated, SPR Therapeutics, Axonics Modulation Technologies Inc., Saluda Medical Pty Limited, MicroTransponder Inc., EndoStim Inc., NeuroMetrix Inc., Second Sight Medical Products Inc., Neurotech International Limited, Neuronix Ltd., Neuronoff Inc.
Download The Full Report For Exclusive Market Findings:
Which Region Is Projected To Lead The Internal Neuromodulation Devices Market During The Forecast Period?
North America was the largest region in the internal neuromodulation devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global internal neuromodulation devices market report during the forecast period. The regions covered in the internal neuromodulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Internal Neuromodulation Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=10222&type=smp
Browse Through More Reports Similar to the Global Internal Neuromodulation Devices Market 2025, By The Business Research Company
Medical And Diagnostic Laboratory Services Global Market Report 2025
Neurology Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report
Magnetic Resonance Imaging Devices And Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model